Pfizer Unlikely to Pursue AstraZeneca Hostile Bid

Pfizer Unlikely to Pursue AstraZeneca Hostile Bid Play

May 5 (Bloomberg) -- Odile Rundquist, an analyst at Helvea SA, discusses Pfizer Inc.'s bid for AstraZeneca Plc. She speaks from Geneva with Guy Johnson on Bloomberg Television's "On the Move." (Source: Bloomberg)

  • On Air Now

    Bloomberg Surveillance Watch Now

  • Next

    In The Loop with Betty Liu

blog comments powered by Disqus